CLNN today
$3.92-$0.08 (-2.00%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minExpanding
Daily trend turns down below $3.02
Key levels
Resistance$4.45
Resistance$4.05
Support$3.60
Support$3.02
Latest news & SEC filings
SEC FilingClene Inc. filed an insider trading report (Form 4)
DealClene Nanomedicine teams with Veristat on ALS drug application
EarningsClene Posts Q3 2026 Results, Gives CNM-Au8 Update
All CLNN news →About Clene
Clene is a drug developer focused on nanocrystal-based treatments made from transition metals. Its main candidate, CNM-Au8, uses gold nanocrystals and is being tested in patients with amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson's disease. The company also makes zinc-silver ionic products for infections and, via its dOrbital unit and a licensing deal with 4Life, sells mineral supplements. It operates mainly in the United States.
Based on the company's 10-K filed Mar 17, 2026.
Nasdaq · Healthcare
Clene Inc. (CLNN)
What Is the Price Target for CLNN?
SEPT Low Target
$31.00
SEPT Mid Target
$31.00
SEPT High Target
$31.00
Analyst Consensus
$31.00
Is CLNN a Buy or Sell Right Now?
Thesis
- •Revenue growing -41.5% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CLNN.
Start Free Trial →Is CLNN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$31.00
17
Moat Score
NONE
1/9
Piotroski Score
-27.5
Altman Z-Score
What Is Smart Money Doing with CLNN?
Insider Signal
SELLING
0 buys / 17 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MATLIN DAVID J | director | Buy | 434,451 | $1.4M | Sep 16, 2026 |
| Etherington Robert Dee | director officer | Buy | 15,244 | $50K | Sep 16, 2026 |
| Mosca Alison | director 10% owner | Buy | 198,171 | $650K | Sep 16, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CLNN Growth Story
Revenue YoY
-41.5%
3yr Revenue CAGR
-24.9%
EPS Growth YoY
N/A
FCF Growth YoY
12.9%
Revenue Trend
DECLINING
Dark Pool Trades for CLNN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CLNN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:30:43 | $3.86 | 3,898 | $$15K | SELL |
| 17:28:28 | $4.10 | 2,100 | $$9K | BUY |
| 16:40:14 | $3.96 | 1,000 | $$4K | SELL |
| 16:28:02 | $3.99 | 1,000 | $$4K | BUY |
| 20:36:38 | $4.00 | 1,136 | $$5K | BUY |
5 dark pool trades shown · $$36K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for CLNN
PREVIEWSEPT Investing provides real-time options flow tracking for CLNN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2.5 | May 21 | 189 | $$5280 | 11 | SWEEP |
| CALL | $2.5 | May 21 | 189 | $$42.2K | 88 | SWEEP |
2 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Clene Inc. (CLNN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CLNN — frequently asked questions
What is CLNN stock price today?
Clene Inc. (CLNN) is at $3.92, down 2.00% (-$0.08) at the Nov 13, 2026 close.
Why is CLNN stock moving today?
Latest CLNN news — Nov 13, 2026: Clene Inc. filed an insider trading report (Form 4) · Nov 13, 2026: Clene Nanomedicine teams with Veristat on ALS drug application
What is the CLNN price target?
The average analyst price target for CLNN is $31.00, ranging from $31 to $31, based on 2 analysts. Latest: H.C. Wainwright maintains on Oct 20, 2026.
What do analysts rate CLNN?
Analyst ratings for CLNN: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did CLNN beat earnings?
CLNN last reported on Aug 14, 2026: EPS -$1.08 vs -$0.37 expected — a miss of 193.5%.
Does CLNN pay a dividend?
CLNN does not currently pay a dividend.
How much debt does CLNN have?
Clene Inc. reported $18M of debt and $10M of cash (Jun 30, 2026).
What are CLNN support and resistance levels?
Support: $3.60, $3.02, $2.28. Resistance: $4.05, $4.45, $4.93.
What are insiders doing with CLNN?
Insider activity: SELLING, 0 buys and 17 sells in the last 90 days.
What is the latest news on CLNN?
Nov 13, 2026: Clene Inc. filed an insider trading report (Form 4) · Nov 13, 2026: Clene Nanomedicine teams with Veristat on ALS drug application · Nov 4, 2026: Clene Posts Q3 2026 Results, Gives CNM-Au8 Update